GlassScriptPhysician profile
Carolyn E Stoy Roberts
NPI 1730449430
$5,333.98
in general payments reported to CMS, 2019-2025
41 companies · $795 in 2025
The $795 reported for 2025 was more than what 82% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $774 · 2020: $737 · 2021: $673 · 2022: $943 · 2023: $910 · 2024: $502 · 2025: $795.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,883 · Education: $324.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,882.77 |
| Education | $324.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $657.77 | 2019-2024 | Liletta, Lo Loestrin Fe, Orilissa |
| Astellas Pharma US INC | $542.21 | 2022-2025 | Veozah, Myrbetriq |
| Minerva Surgical, INC | $489.07 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $387.08 | 2023-2025 | Myfembree |
| Olympus America INC. | $380.25 | 2019-2025 | Olympus, Olympus, Cysto-Nephro Videoscope |
| Therapeuticsmd, INC. | $352.72 | 2019-2021 | |
| Hologic Sales and Service, LLC | $316.40 | 2020-2025 | Novasure, Myosure Tissue Removal Device, Acessa Provu System |
| Depuy Synthes Sales INC. | $238.58 | 2020 | |
| Organon LLC | $188.32 | 2021-2024 | Nexplanon |
| Exeltis, USA INC. | $161.23 | 2019-2024 | Slynd |
| Evofem Biosciences, INC. | $133.08 | 2021-2024 | Phexxi |
| Mayne Pharma Commercial LLC | $116.88 | 2021-2025 | |
| Myovant Sciences INC. | $104.23 | 2022 | |
| Millicent US INC | $101.35 | 2019-2025 | Intrarosa, Femring |
| Merck Sharp & Dohme LLC | $92.70 | 2019-2021 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carolyn Roberts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.